We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$70.1B
AUM Growth
-$3.23B
Cap. Flow
-$4.59B
Cap. Flow %
-6.55%
Top 10 Hldgs %
10.04%
Holding
5,020
New
596
Increased
1,359
Reduced
1,925
Closed
795

Sector Composition

Rank Sector Weight
1 Communication Services 9.11%
2 Healthcare 7.95%
3 Consumer Discretionary 7.93%
4 Financials 7.4%
5 Technology 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$343B
$356M 0.51%
4,411,287
+3,972,423
+905% +$313M
MSFT icon
27
Microsoft
MSFT
$2.84T
$337M 0.48%
8,232,155
+940,369
+13% +$35.3M
DVA icon
28
DaVita
DVA
$15.1B
$329M 0.47%
4,774,324
+269,691
+6% +$17.9M
MRK icon
29
Merck
MRK
$324B
$319M 0.46%
5,891,033
-1,460,091
-20% -$75.6M
ABBV icon
30
AbbVie
ABBV
$458B
$301M 0.43%
5,859,863
+2,262,977
+63% +$114M
OXY icon
31
Occidental Petroleum
OXY
$57B
$294M 0.42%
3,223,411
+485,137
+18% +$43.3M
V icon
32
Visa
V
$677B
$293M 0.42%
5,428,744
+3,174,644
+141% +$176M
DTV
33
DELISTED
DIRECTV COM STK (DE)
DTV
$291M 0.42%
3,811,796
+1,473,943
+63% +$108M
STZ icon
34
Constellation Brands
STZ
$22.2B
$290M 0.41%
3,414,725
+649,633
+23% +$51.7M
BHC icon
35
Bausch Health
BHC
$1.65B
$289M 0.41%
2,191,015
+609,949
+39% +$83.4M
APC
36
DELISTED
Anadarko Petroleum
APC
$278M 0.4%
3,278,846
+1,031,014
+46% +$84.5M
FRX
37
DELISTED
FOREST LABORATORIES INC
FRX
$268M 0.38%
2,904,978
+2,011,620
+225% +$162M
JNJ icon
38
Johnson & Johnson
JNJ
$634B
$268M 0.38%
2,728,041
-1,932,802
-41% -$179M
MA icon
39
PUT
Mastercard
MA
$477B
$267M 0.38%
3,578,700
-1,315,300
-27% -$103M
WFC icon
40
Wells Fargo
WFC
$261B
$263M 0.37%
5,283,923
-659,632
-11% -$30.7M
YHOO
41
PUT
DELISTED
Yahoo Inc
YHOO
$261M 0.37%
7,277,000
-1,403,900
-16% -$53.6M
VZ icon
42
Verizon
VZ
$194B
$257M 0.37%
5,406,637
+5,222,151
+2,831% +$247M
JNJ icon
43
PUT
Johnson & Johnson
JNJ
$634B
$255M 0.36%
2,599,200
-477,500
-16% -$44.3M
TMO icon
44
Thermo Fisher Scientific
TMO
$211B
$254M 0.36%
2,109,938
+553,879
+36% +$65.9M
BKNG icon
45
CALL
Booking.com
BKNG
$138B
$251M 0.36%
5,270,000
+1,047,500
+25% +$51.7M
PFE icon
46
Pfizer
PFE
$140B
$251M 0.36%
8,223,341
+5,084,512
+162% +$152M
CF icon
47
CF Industries
CF
$19.2B
$244M 0.35%
4,676,455
-79,505
-2% -$3.87M
MU icon
48
PUT
Micron Technology
MU
$1.04T
$243M 0.35%
10,279,400
+2,151,000
+26% +$51.1M
MHFI
49
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$242M 0.35%
3,175,564
+1,634,279
+106% +$128M
EMC
50
DELISTED
EMC CORPORATION
EMC
$240M 0.34%
8,748,477
+6,842,084
+359% +$178M

Similar funds

D.E. Shaw & Co's Q1 2014 Portfolio in Review

As of Q1 2014, D.E. Shaw & Co held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

D.E. Shaw & Co withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 9.1% of assets, up from 6.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, D.E. Shaw & Co opened a new position in Veren worth $53.3M.

  • D.E. Shaw & Co's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
  • D.E. Shaw & Co added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
  • D.E. Shaw & Co's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
  • D.E. Shaw & Co fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
  • D.E. Shaw & Co's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
  • D.E. Shaw & Co opened 596 new positions and closed 795 in Q1 2014.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $70.1B.

Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.